By Richard Oswald Not too long ago, the worlds pharmaceutical companies lobbied Congress to drop strict safety guidelines saying those placed an undue burden on America. It was unconstitutional they said, by driving up the cost of medicine. US consumers shouldn’t care where medicine came from. It was none of their business actually, so long as they received adequate assurances of safety and effectiveness. It was the most efficient way, they said, to keep prices low. Pill imports Read More …
A letter dated November 4, 2013 from USDA Office of Inspector General contained some very welcome news, specifically: “…your FOIA appeal is granted”. For some time OCM’s legitimate request for material relating to a particular OIG audit had met with what could best be described as evasion and stalling. But, unlike previous correspondence from this agency, this letter was signed personally by the Inspector General, Phyllis K. Fong. Background: Back in July of 2010, an outside independent audit Read More …